Connection

Kenneth Cummings to Nicotine

Back to Details
This is a "connection" page, showing publications Kenneth Cummings has written about Nicotine.
Kenneth Cummings
Connection Strength
7.187
Nicotine
  1. A new classification system for describing concurrent use of nicotine vaping products alongside cigarettes (so-called 'dual use'): findings from the ITC-4 Country Smoking and Vaping wave 1 Survey. Addiction. 2019 10; 114 Suppl 1:24-34.
    View in: PubMed
    Score: 0.518
  2. A modeling approach to gauging the effects of nicotine vaping product use on cessation from cigarettes: what do we know, what do we need to know? Addiction. 2019 10; 114 Suppl 1:86-96.
    View in: PubMed
    Score: 0.511
  3. A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects. Cancer Epidemiol Biomarkers Prev. 2017 12; 26(12):1795-1803.
    View in: PubMed
    Score: 0.470
  4. Costs of giving out free nicotine patches through a telephone quit line. J Public Health Manag Pract. 2011 May-Jun; 17(3):E16-23.
    View in: PubMed
    Score: 0.299
  5. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res. 2011 Feb; 13(2):94-102.
    View in: PubMed
    Score: 0.291
  6. Does the number of free nicotine patches given to smokers calling a quitline influence quit rates: results from a quasi-experimental study. BMC Public Health. 2010 Apr 07; 10:181.
    View in: PubMed
    Score: 0.278
  7. Adverse effects with use of nicotine replacement therapy among quitline clients. Nicotine Tob Res. 2009 Apr; 11(4):408-17.
    View in: PubMed
    Score: 0.259
  8. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings? Nicotine Tob Res. 2007 Nov; 9(11):1139-46.
    View in: PubMed
    Score: 0.235
  9. Changes in nicotine intake and cigarette use over time in two nationally representative cross-sectional samples of smokers. Am J Epidemiol. 2006 Oct 15; 164(8):750-9.
    View in: PubMed
    Score: 0.215
  10. Free nicotine patch giveaway program 12-month follow-up of participants. Am J Prev Med. 2006 Aug; 31(2):181-4.
    View in: PubMed
    Score: 0.213
  11. Concurrent quit & win and nicotine replacement therapy voucher giveaway programs: participant characteristics and predictors of smoking abstinence. J Public Health Manag Pract. 2006 Jan-Feb; 12(1):52-9.
    View in: PubMed
    Score: 0.207
  12. Impact of nicotine replacement therapy on smoking behavior. Annu Rev Public Health. 2005; 26:583-99.
    View in: PubMed
    Score: 0.193
  13. What do Marlboro Lights smokers know about low-tar cigarettes? Nicotine Tob Res. 2004 Dec; 6 Suppl 3:S323-32.
    View in: PubMed
    Score: 0.192
  14. Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine Tob Res. 2004 Dec; 6 Suppl 3:S333-40.
    View in: PubMed
    Score: 0.192
  15. A Decision-Theoretic Public Health Framework for Heated Tobacco and Nicotine Vaping Products. Int J Environ Res Public Health. 2022 Oct 18; 19(20).
    View in: PubMed
    Score: 0.166
  16. The Public Health Gains Had Cigarette Companies Chosen to Sell Very Low Nicotine Cigarettes. Nicotine Tob Res. 2021 02 16; 23(3):438-446.
    View in: PubMed
    Score: 0.147
  17. Identifying factors that conjointly influence nicotine vaping product relative harm perception among smokers and recent ex-smokers: Findings from the 2016 ITC Four Country Smoking and Vaping Survey. Drug Alcohol Depend. 2021 01 01; 218:108370.
    View in: PubMed
    Score: 0.144
  18. Concurrent Daily and Non-Daily Use of Heated Tobacco Products with Combustible Cigarettes: Findings from the 2018 ITC Japan Survey. Int J Environ Res Public Health. 2020 03 22; 17(6).
    View in: PubMed
    Score: 0.139
  19. Behavioral Economic Purchase Tasks to Estimate Demand for Novel Nicotine/tobacco Products and Prospectively Predict Future Use: Evidence From The Netherlands. Nicotine Tob Res. 2019 05 21; 21(6):784-791.
    View in: PubMed
    Score: 0.131
  20. Characteristics of nicotine vaping products used by participants in the 2016 ITC Four Country Smoking and Vaping Survey. Addiction. 2019 10; 114 Suppl 1:15-23.
    View in: PubMed
    Score: 0.130
  21. Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings From ITC Surveys in Five Countries. Nicotine Tob Res. 2017 Sep 01; 19(9):1040-1047.
    View in: PubMed
    Score: 0.116
  22. Tobacco Use Prevalence and Outcomes Among Perinatal Patients Assessed Through an "Opt-out" Cessation and Follow-Up Clinical Program. Matern Child Health J. 2017 Sep; 21(9):1790-1797.
    View in: PubMed
    Score: 0.116
  23. Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993. Tob Control. 1997; 6 Suppl 2:S63-70.
    View in: PubMed
    Score: 0.111
  24. Trends in E-Cigarette Awareness, Trial, and Use Under the Different Regulatory Environments of Australia and the United Kingdom. Nicotine Tob Res. 2015 Oct; 17(10):1203-11.
    View in: PubMed
    Score: 0.095
  25. Use and effectiveness of transdermal nicotine in primary care settings. Arch Fam Med. 1994 Aug; 3(8):682-9.
    View in: PubMed
    Score: 0.094
  26. Trends in use of electronic nicotine delivery systems by adolescents. Addict Behav. 2014 Jan; 39(1):338-40.
    View in: PubMed
    Score: 0.088
  27. Nicotine replacement therapy distribution to light daily smokers calling a quitline. Nicotine Tob Res. 2013 Sep; 15(9):1572-7.
    View in: PubMed
    Score: 0.085
  28. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med. 2013 Mar; 44(3):207-15.
    View in: PubMed
    Score: 0.085
  29. Educating smokers about their cigarettes and nicotine medications. Health Educ Res. 2010 Aug; 25(4):678-86.
    View in: PubMed
    Score: 0.068
  30. The impact of changing nicotine replacement therapy licensing laws in the United Kingdom: findings from the International Tobacco Control Four Country Survey. Addiction. 2009 Aug; 104(8):1420-7.
    View in: PubMed
    Score: 0.066
  31. Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey. Addiction. 2008 Oct; 103(10):1696-703.
    View in: PubMed
    Score: 0.063
  32. Weight gain following smoking cessation: a possible role for nicotine replacement in weight management. Addict Behav. 1987; 12(2):151-5.
    View in: PubMed
    Score: 0.055
  33. Current and emerging treatment approaches for tobacco dependence. Curr Oncol Rep. 2006 Nov; 8(6):475-83.
    View in: PubMed
    Score: 0.055
  34. Smoking expectancies for flavored and non-flavored cigarettes among college students. Addict Behav. 2007 Jun; 32(6):1252-61.
    View in: PubMed
    Score: 0.054
  35. Cigarette yields and human exposure: a comparison of alternative testing regimens. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1495-501.
    View in: PubMed
    Score: 0.054
  36. Comparing smoking behaviors and exposures from flavored and unflavored cigarettes. Addict Behav. 2007 Apr; 32(4):869-74.
    View in: PubMed
    Score: 0.054
  37. Smoking topography, brand switching, and nicotine delivery: results from an in vivo study. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1370-5.
    View in: PubMed
    Score: 0.050
  38. Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet. 2005 May 28-Jun 3; 365(9474):1849-54.
    View in: PubMed
    Score: 0.049
  39. A randomized trial to promote pharmacotherapy use and smoking cessation in a Medicaid population (United States). Cancer Causes Control. 2005 May; 16(4):373-82.
    View in: PubMed
    Score: 0.049
  40. Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res. 2004 Dec; 6 Suppl 3:S303-10.
    View in: PubMed
    Score: 0.048
  41. Use of and beliefs about light cigarettes in four countries: findings from the International Tobacco Control Policy Evaluation Survey. Nicotine Tob Res. 2004 Dec; 6 Suppl 3:S311-21.
    View in: PubMed
    Score: 0.048
  42. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res. 2004 Dec; 6 Suppl 3:S363-9.
    View in: PubMed
    Score: 0.048
  43. The Australia Smoking and Vaping Model: The Potential Impact of Increasing Access to Nicotine Vaping Products. Nicotine Tob Res. 2023 02 09; 25(3):486-497.
    View in: PubMed
    Score: 0.042
  44. Do Social Norms for Cigarette Smoking and Nicotine Vaping Product Use Predict Trying Nicotine Vaping Products and Attempts to Quit Cigarette Smoking Amongst Adult Smokers? Findings From the 2016-2020 International Tobacco Control Four Country Smoking and Vaping Surveys. Nicotine Tob Res. 2023 02 09; 25(3):505-513.
    View in: PubMed
    Score: 0.042
  45. Do Current Smokers and Ex-Smokers Who Use Nicotine Vaping Products Daily Versus Weekly Differ on Their Reasons for Vaping? Findings from the 2020 ITC Four Country Smoking and Vaping Survey. Int J Environ Res Public Health. 2022 Oct 29; 19(21).
    View in: PubMed
    Score: 0.041
  46. Adult smokers' discussions about vaping with health professionals and subsequent behavior change: a cohort study. Addiction. 2022 11; 117(11):2933-2942.
    View in: PubMed
    Score: 0.041
  47. Oral Nicotine Product Awareness and Use Among People Who Smoke and Vape in the U.S. Am J Prev Med. 2022 10; 63(4):611-618.
    View in: PubMed
    Score: 0.040
  48. Characterizing Heated Tobacco Product Use Among Adult Cigarette Smokers and Nicotine Vaping Product Users in the 2018 ITC Four Country Smoking & Vaping Survey. Nicotine Tob Res. 2022 03 01; 24(4):493-502.
    View in: PubMed
    Score: 0.040
  49. Validation of the Wave 1 and Wave 2 Population Assessment of Tobacco and Health (PATH) Study Indicators of Tobacco Dependence Using Biomarkers of Nicotine Exposure Across Tobacco Products. Nicotine Tob Res. 2022 01 01; 24(1):10-19.
    View in: PubMed
    Score: 0.039
  50. Responses to potential nicotine vaping product flavor restrictions among regular vapers using non-tobacco flavors: Findings from the 2020 ITC Smoking and Vaping Survey in Canada, England and the United States. Addict Behav. 2022 02; 125:107152.
    View in: PubMed
    Score: 0.039
  51. Patterns of Non-Cigarette Tobacco and Nicotine Use Among Current Cigarette Smokers and Recent Quitters: Findings From the 2020 ITC Four Country Smoking and Vaping Survey. Nicotine Tob Res. 2021 08 18; 23(9):1611-1616.
    View in: PubMed
    Score: 0.038
  52. "Don't Know" Responses for Nicotine Vaping Product Features among Adult Vapers: Findings from the 2018 and 2020 ITC Four Country Smoking and Vaping Surveys. Int J Environ Res Public Health. 2021 07 27; 18(15).
    View in: PubMed
    Score: 0.038
  53. Characteristics and changes over time of nicotine vaping products used by vapers in the 2016 and 2018 ITC Four Country Smoking and Vaping Surveys. Tob Control. 2022 08; 31(e1):e66-e73.
    View in: PubMed
    Score: 0.037
  54. Where Do Vapers Buy Their Vaping Supplies? Findings from the International Tobacco Control (ITC) 4 Country Smoking and Vaping Survey. Int J Environ Res Public Health. 2019 01 26; 16(3).
    View in: PubMed
    Score: 0.032
  55. The need for a comprehensive framework. Addiction. 2017 01; 112(1):22-24.
    View in: PubMed
    Score: 0.028
  56. Developing Consistent and Transparent Models of E-cigarette Use: Reply to Glantz and Soneji et al. Nicotine Tob Res. 2017 02; 19(2):268-270.
    View in: PubMed
    Score: 0.027
  57. Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey. Nicotine Tob Res. 2015 Apr; 17(4):463-72.
    View in: PubMed
    Score: 0.025
  58. Biochemical changes, early brain growth suppression and impaired detour learning in nicotine-treated chicks. Brain Res Dev Brain Res. 1994 Dec 16; 83(2):181-9.
    View in: PubMed
    Score: 0.024
  59. Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. Nicotine Tob Res. 2014 Jul; 16(7):992-9.
    View in: PubMed
    Score: 0.023
  60. Role of cigarette sensory cues in modifying puffing topography. Drug Alcohol Depend. 2012 Jul 01; 124(1-2):1-10.
    View in: PubMed
    Score: 0.020
  61. Does offering more support calls to smokers influence quit success? J Public Health Manag Pract. 2011 May-Jun; 17(3):E9-15.
    View in: PubMed
    Score: 0.019
  62. Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers. Cancer Epidemiol Biomarkers Prev. 2010 Jun; 19(6):1389-98.
    View in: PubMed
    Score: 0.018
  63. How did UK cigarette makers reduce tar to 10 mg or less? BMJ. 2006 Feb 04; 332(7536):302.
    View in: PubMed
    Score: 0.013
  64. Reports of smoking withdrawal symptoms over a 21 day period of abstinence. Addict Behav. 1985; 10(4):373-81.
    View in: PubMed
    Score: 0.012
  65. The near-universal experience of regret among smokers in four countries: findings from the International Tobacco Control Policy Evaluation Survey. Nicotine Tob Res. 2004 Dec; 6 Suppl 3:S341-51.
    View in: PubMed
    Score: 0.012
  66. Impact of economic policies on reducing tobacco use among Medicaid clients in New York. Prev Med. 2003 Jul; 37(1):68-70.
    View in: PubMed
    Score: 0.011
  67. Patterns of use of a free nicotine patch program for Medicaid and uninsured patients. J Natl Med Assoc. 1997 May; 89(5):325-8.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.